THERESA GILLIS: Open Payments
NPI 1306024476 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 21 payments from 8 companies in 2025. Trend: 2023 $960 · 2024 $327 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 9 | $269 |
| IMMUNITYBIO, INC. | 2 | $179 |
| Endo USA, Inc. | 4 | $102 |
| Boston Scientific Corporation | 1 | $47 |
| UROGEN PHARMA, INC. | 2 | $42 |
| Janssen Biotech, Inc. | 1 | $24 |
| Teleflex LLC | 1 | $24 |
| COLOPLAST CORP | 1 | $16 |
Products named: GEMTESA, ANKTIVA, AVEED, XIAFLEX, SpaceOAR System, JELMYTO, ERLEADA, UROLIFT.
Industry payments across MD — which companies pay providers there.
